Codagenix (Series B Extension)
Funding Details
- Awarder
- Inbox
- Date Award
- February 15, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $25,000,000
Company Info
- Company Description
- Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.
- Market
- Infectious disease, cancer, and animal health
- Location
- Farmingdale, New York, USA
- Coinvestors
- Adjuvant Capital, Euclidean Capital, Serum Institute of India